DRUG
Desmopressin
40 micrograms Nasal Desmopressin.
Intranasal Desmopressin vs IV Ketorolac in Renal Colic Pain Control
Status
Completed
Phase
Not applicable
Enrollment
40
Locations
0
Results
Not posted
Publications
0
Study summary
What the protocol is testing.
The aim of this study is the comparison of efficacy of intravenous ketorolac and intranasal desmopressin in renal colic patients pain control.
Full detailed description
40 renal colic patients have been divided into 2 groups randomly, one group has been received 30mg intravenous Ketorolac and 4 puffs nasal Normal Saline while other has been received 40 micrograms nasal Desmopressin and 1cc intravenous Normal Saline. Pain Score before drug administration,also 10, 30 and 60 minutes after drug administration has been measured bye Visual Analogue Scale ( VAS ).
Interventions
Treatment arms and agents.
DRUG
Ketorolac
30mg intravenous Ketorolac.
DRUG
Normal Saline
1cc intravenous Normal Saline.
DRUG
Normal Saline
4 puffs nasal Normal Saline.
Timeline
From registration to results.
First posted
Oct 19, 2016
Study start
Jan 2015
Primary completion
Feb 2016
Study completion
Apr 2016
Results posted
Not reported
Registry updated
Oct 19, 2016
Outcomes
What the study measures.
Primary outcomes
Pain score
Time frame · Pain score change from baseline pain score before intervention 10, 30 and 60 minutes after intervention
Secondary outcomes
Not reported in the indexed record.
Eligibility
Who can take part.
- Minimum age
- 16 Years
- Maximum age
- 50 Years
- Sex
- ALL
- Healthy volunteers
- No
Inclusion Criteria: * renal colic patients Exclusion Criteria: * history of hypertension and cardiac disease * pregnant patients * use of analgesic within 4 hours before intervention
Study locations
0 registered sites.
No country data reported. Showing up to 24 locations stored in the fast local snapshot.
No study locations reported.
Publications
Results and literature.
No PMID-linked publications were present in this registry snapshot.
Related trials
More studies on Desmopressin.
NCT IDStudyPhase / statusEnrollmentUpdated
Randomized Controlled Clinical Study on the Prophylactic Intraoperative Use of Desmopressin in Complex Sellar Region Tumors
Zhaoyun Zhang · Craniopharyngiomas · Pituitary Macroadenoma
Phase 4
Enrolling by invitation
152
2026-07
Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Cushing Syndrome
Phase 2
Recruiting
140
2026-07
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
Hamilton Health Sciences Corporation · Chronic Kidney Diseases · Acute Kidney Injury
Phase 3
Recruiting
100
2026-05
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of Hyponatremia
Rochester General Hospital · Hyponatremia Symptomatic · Osmotic Demyelination Syndrome
Not applicable
Enrolling by invitation
800
2026-05
DDAVP for Pituitary Adenoma
National Institute of Neurological Disorders and Stroke (NINDS) · Cushing's Disease · Pituitary Adenoma
Not applicable
Recruiting
22
2026-04
Vitamin D Versus Desmopressin Versus Combination Therapy in Children With Primary Monosymptomatic Nocturnal Enuresis and Vitamin D Deficiency
Ain Shams University · Nocturnal Enuresis · Vitamin D Deficiency
Not applicable
Completed
90
2026-03
Ginkgo Biloba vs Desmopressin in Treatment of Children With Monosymptomatic Nocturnal Enuresis
Menoufia University · Nocturnal Enuresis in Children · Desmopressin
Not applicable
Completed
398
2026-01
NOCDURNA PASS Study Using Registries in Denmark, Germany and Sweden
Ferring Pharmaceuticals · Adverse Drug Event
Not applicable
Completed
1,099,551
2025-12
Related PeptideStat pages
Put the record in context.
Research pages describe evidence. Vendor pages, where available, describe independently tracked research-product listings and are not clinical recommendations.